| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Jeremy Castle last filed a Form 4 in May 2025, as Chief Operating Officer at TOI. Jeremy Castle's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 247,031 shares of TOI. Net of sales, the TOI filings show accumulation of 9,056 shares.
Jeremy Castle has 6 Form 4 filings on record from November 2023 to May 2025, all as Chief Operating Officer at Oncology Institute (TOI), 2023–2025.
The 9 reported transactions were 3 stock awards, 2 dispositions back to the company, 2 open-market purchases and 2 option or other derivative awards.
Counted by filing, the open-market trades come to 1 purchase worth about $9K and no sales.
The only open-market purchase was 9,056 shares of TOI at an average $1.04 on March 26, 2025, about $9K. Twelve months later TOI was up 156%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Chief Operating Officer | Buy | 9,056 | $1.04 | $9,433.64 | +11.1% | +94.2% | +156.2% |